Table 2.
First blood tests and cerebrospinal fluid (CSF) examinations.
| Case | Serum | CSF | ||||||
|---|---|---|---|---|---|---|---|---|
| VDRL | Trep. T. | Leukoc/mm3 | Protein (mg/dl) | Gammagl. (%) | VDRL | TPHA | ||
| 1 | 1/8 | TPHA + (>1/1024) | 13 | 76 | 49.7 | 1/8 | >1/1024 | |
| 2 | 1/16 | FTA-Abs + | 10 | 64 | 20.3 | 1/4 | >1/1024 | |
| 3 | NA | FTA-Abs + | 58 | 50 | 26.3 | WR 1/4 | 1/512 | |
| 4 | 1/1 | FTA-Abs + | 36 | 98 | 31.3 | 1/4 | + | |
| 5 | NA | FTA-Abs + | 5 | 60 | 42.6 | + | + | |
| 6 | 1/8 | TPHA + (1/256) | 3 | 33 | 35.9 | 1/2 | 1/256 | |
| 7 | 1/32 | FTA-Abs + | 165 | 127 | 31.8 | WR+ | 1/512 | |
| 8 | NR | ELISA + | 45 | 70 | 39.6 | + | 1/512 | |
| 9 | 1/256 | TPHA + | 133 | 206 | 33.9 | 1/128 | + | |
ELISA: Enzyme linked immunoassay; FTA-Abs: fluorescent treponemal antibody-absorbed; Gammagl.: gammaglobulin; Leukoc: leukocytes; NA: not available; NR: Non reactive; WR: Wassermann's reaction; TPHA: Treponema pallidum haemagglutination assay.